← Mechanisms of action
CD28
SINGLE PROTEINHomo sapiens
Preferred name: T-cell-specific surface glycoprotein CD28 ChEMBL ↗
Linked proteins
Drugs acting on this target (28)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| mdx2003 | Activator | experimental | mAb | CD28 activator |
| rndo-564 | Activator | experimental | mAb | CD28 activator |
| regn7945 | Agonist | experimental | mAb | CD28 agonist |
| sar443216 | Agonist | experimental | mAb | CD28 |
| tgn-1412 | Agonist | experimental | mAb | CD28 agonist |
| lulizumab pegol | Antagonist | experimental | mAb | CD28 antagonist |
| sar442257 | Antagonist | experimental | mAb | CD28 |
| sar442257 | Binding agent | experimental | mAb | CD28 |
| sgn-bb228 | Binding agent | experimental | mAb | CD28 |
| anti-ley-scfv-cd28-zeta vector | Immunity, passive | experimental | Cell therapy | CD28 immunity, passive |
| car.k.28 | Immunity, passive | experimental | Cell therapy | CD28 immunity, passive |
| alpn-101 | Inhibitor | experimental | mAb | CD28 inhibitor |
| alpn-202 | Inhibitor | experimental | mAb | CD28 inhibitor |
| cc312 | Inhibitor | experimental | mAb | CD28 inhibitor |
| fr104 | Inhibitor | experimental | mAb | CD28 inhibitor |
| jnj-87189401 | Inhibitor | experimental | mAb | CD28 inhibitor |
| lulizumab pegol | Inhibitor | experimental | mAb | CD28 inhibitor |
| mdx2001 | Inhibitor | experimental | mAb | CD28 inhibitor |
| mdx2004 | Inhibitor | experimental | mAb | CD28 inhibitor |
| regn5668 | Inhibitor | experimental | mAb | CD28 inhibitor |
| regn5678 | Inhibitor | experimental | mAb | CD28 inhibitor |
| regn5837 | Inhibitor | experimental | mAb | CD28 inhibitor |
| regn7075 | Inhibitor | experimental | mAb | CD28 inhibitor |
| reltecimod | Inhibitor | experimental | Peptide | CD28 inhibitor |
| rm28 | Inhibitor | experimental | mAb | CD28 inhibitor |
| sss59 | Inhibitor | experimental | mAb | CD28 inhibitor |
| tgn-1412 | Inhibitor | experimental | mAb | CD28 inhibitor |
| xmab®808 | Inhibitor | experimental | mAb | CD28 inhibitor |